Related Experiment Video
Updated: Aug 15, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1
Jiliang Zhou1, Guoqing Hu, B Paul Herring
1Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, Indiana 46202-5120, USA.
Abstract:
Understanding the mechanism of smooth muscle cell (SMC) differentiation will provide the foundation for elucidating SMC-related diseases, such as atherosclerosis, restenosis, and asthma. In the current study, overexpression of Elk-1 in SMCs down-regulated expression of several endogenous smooth muscle-restricted proteins, including telokin, SM22alpha, and smooth muscle alpha-actin. In contrast, down-regulation of endogenous Elk-1 in smooth muscle cells increased the expression of only telokin and SM22alpha, suggesting that smooth muscle-specific promoters are differentially sensitive to the inhibitory effects of Elk-1. Consistent with this, overexpression of the DNA binding domain of Elk-1, which acts as a dominant-negative protein by displacing endogenous Elk-1, enhanced the expression of telokin and SM22alpha without affecting expression of smooth muscle alpha-actin. Elk-1 suppressed the activity of smooth muscle-restricted promoters, including the telokin promoter that does not contain a consensus Elk-1 binding site, through its ability to block myocardin-induced activation of the promoters. Gel mobility shift and chromatin immunoprecipitation assays revealed that Elk-1 binds to a nonconsensus binding site in the telokin promoter and Elk-1 binding is dependent on serum response factor (SRF) binding to a nearby CArG box. Although overexpression of the SRF-binding B-box domain of Elk-1 is sufficient to repress the myocardin activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain. In addition, reporter gene assays demonstrate that an intact Elk-1 binding site in the telokin promoter is required for Elk-1 to maximally inhibit promoter activity. Together, these data suggest that the differential sensitivity of smooth muscle-specific genes to inhibition by Elk-1 may play a role in the complex changes in smooth muscle-specific protein expression that are observed under pathological conditions.
Insights
Elk-1 protein inhibits smooth muscle cell (SMC) differentiation by repressing specific gene promoters. This differential gene regulation by Elk-1 may contribute to SMC-related diseases like atherosclerosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cardiovascular Research
Background:
- Smooth muscle cell (SMC) differentiation is crucial for understanding SMC-related diseases.
- Elucidating the regulatory mechanisms of SMC differentiation is essential for disease intervention.
Purpose of the Study:
- To investigate the role of Elk-1 in regulating smooth muscle cell differentiation.
- To understand how Elk-1 affects the expression of key smooth muscle-specific proteins and their promoters.
Main Methods:
- Overexpression and down-regulation of Elk-1 in SMCs.
- Reporter gene assays to assess promoter activity.
- Gel mobility shift and chromatin immunoprecipitation assays to study protein-DNA interactions.
Main Results:
- Overexpression of Elk-1 down-regulated telokin, SM22alpha, and smooth muscle alpha-actin.
- Elk-1 inhibited smooth muscle-specific promoter activity, including the telokin promoter.
- Elk-1 binding to the telokin promoter was dependent on serum response factor (SRF) binding.
Conclusions:
- Elk-1 plays a significant role in suppressing SMC differentiation.
- Differential sensitivity of SMC genes to Elk-1 inhibition may underlie pathological changes in SMCs.
- Elk-1's interaction with SRF is critical for its regulatory function on SMC gene promoters.
More Related Videos
Related Concept Videos
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Master Transcription Regulators
Regulation of Angiogenesis and Blood Supply

